Open Access
Ann Toxicol Anal
Volume 21, Numéro 2, 2009
Page(s) 61 - 65
Publié en ligne 12 juin 2009
  1. Abel EL, Sokol RJ. Incidence of fetal alcohol syndrome and economic impact of FAS-related anomalies. Drug Alcohol Depend. 1987; 19(1): 51-70. [CrossRef] [PubMed]
  2. Abel EL, Sokol RJ. Fetal alcohol syndrome is now leading cause of mental retardation. Lancet. 1986; 2(8517): 1222. [CrossRef]
  3. Abel EL. An update on incidence of FAS: FAS is not an equal opportunity birth defect. Neurotoxicol Teratol. 1995; 17(4): 437-443. [CrossRef] [PubMed]
  4. Sampson PD, Streissguth AP, Bookstein FL, Little RE, Clarren SK, Dehaene P, Hanson JW, Graham JM, Jr. Incidence of fetal alcohol syndrome and prevalence of alcohol-related neurodevelopmental disorder. Teratology. 1997; 56(5): 317-326. [CrossRef] [PubMed]
  5. Streissguth AP, Bookstein FL, Barr HM, Sampson PD, O'Malley K, Young JK. Risk factors for adverse life outcomes in fetal alcohol syndrome and fetal alcohol effects. J Dev Behav Pediatr. 2004; 25(4): 228-238. [CrossRef] [PubMed]
  6. Olson HC, Jirikovic T, Kartin D. Responding to the chanllenge of early intervention for fetal alcohol spectrum disorders. Infants Young Child. 2007; 20172-189.
  7. Chudley AE, Conry J, Cook JL, Loock C, Rosales T, LeBlanc N. Fetal alcohol spectrum disorder: Canadian guidelines for diagnosis. CMAJ. 2005; 172: S1-S21. [CrossRef] [PubMed]
  8. Russell M, Martier SS, Sokol RJ, Mudar P, Jacobson S, Jacobson J. Detecting risk drinking during pregnancy: a comparison of four screening questionnaires. Am J Public Health. 1996; 86(10): 1435-1439. [CrossRef] [PubMed]
  9. Ernhart CB, Morrow-Tlucak M, Sokol RJ, Martier S. Underreporting of alcohol use in pregnancy. Alcohol Clin Exp Res. 1988; 12(4): 506-511. [CrossRef] [PubMed]
  10. Wurst FM, Kelso E, Weinmann W, Pragst F, Yegles M, Sundstrom P I. Measurement of direct ethanol metabolites suggests higher rate of alcohol use among pregnant women than found with the AUDIT–a pilot study in a population-based sample of Swedish women. Am J Obstet Gynecol. 2008; 198(4): 407-5. [CrossRef] [PubMed]
  11. Alvik A, Haldorsen T, Groholt B, Lindemann R. Alcohol consumption before and during pregnancy comparing concurrent and retrospective reports. Alcohol Clin Exp Res. 2006; 30(3): 510-515. [CrossRef] [PubMed]
  12. Bearer CF, Lee S, Salvator AE, Minnes S, Swick A, Yamashita T, Singer LT. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure. Alcohol Clin Exp Res. 1999; 23(3): 487-493. [PubMed]
  13. Bearer CF, Jacobson JL, Jacobson SW, Barr D, Croxford J, Molteno CD, Viljoen DL, Marais AS, Chiodo LM, Cwik AS. Validation of a new biomarker of fetal exposure to alcohol. J Pediatr. 2003; 143(4): 463-469. [CrossRef] [PubMed]
  14. Bearer CF, Santiago LM, O'Riordan MA, Buck K, Lee SC, Singer LT. Fatty acid ethyl esters: quantitative biomarkers for maternal alcohol consumption. J Pediatr. 2005; 146(6): 824-830. [CrossRef] [PubMed]
  15. Klein J, Chan D, Koren G. Neonatal hair analysis as a biomarker for in utero alcohol exposure. N Engl J Med. 2002; 347(25): 2086. [CrossRef] [PubMed]
  16. Klein J, Karaskov T, Korent G. Fatty acid ethyl esters: a novel biologic marker for heavy in utero ethanol exposure: a case report. Ther Drug Monit. 1999; 21(6): 644-646. [CrossRef] [PubMed]
  17. Moore CM and Lewis D. Fatty acid ethyl esters in meconium: biomarkers for the detection of alcohol exposure in neonates. Clin Chim Acta. 2001; 312(1-2): 235-237. [CrossRef] [PubMed]
  18. Moore C, Jones J, Lewis D, Buchi K. Prevalence of fatty acid ethyl esters in meconium specimens. Clin Chem. 2003; 49(1): 133-136. [CrossRef] [PubMed]
  19. Chan D, Caprara D, Blanchette P, Klein J, Koren G. Recent developments in meconium and hair testing methods for the confirmation of gestational exposures to alcohol and tobacco smoke. Clin Biochem. 2004; 37(6): 429-438. [CrossRef] [PubMed]
  20. Caprara DL, Brien JF, Iqbal U, Reynolds JN, Klein J, Koren G. A Guinea pig model for the identification of in utero alcohol exposure using fatty acid ethyl esters in neonatal hair. Pediatr Res. 2005; 58(6): 1158-1163. [CrossRef] [PubMed]
  21. Caprara DL, Klein J, Koren G. Baseline measures of fatty acid ethyl esters in hair of neonates born to abstaining or mild social drinking mothers. Ther Drug Monit. 2005; 27(6): 811-815. [CrossRef] [PubMed]
  22. Caprara DL, Klein J, Koren G. Diagnosis of fetal alcohol spectrum disorder (FASD): fatty acid ethyl esters and neonatal hair analysis. Ann Ist Super Sanita. 2006; 42(1): 39-45. [PubMed]
  23. Chan D, Klein J, Karaskov T, Koren G. Fetal exposure to alcohol as evidenced by fatty acid ethyl esters in meconium in the absence of maternal drinking history in pregnancy. Ther Drug Monit. 2004; 26(5): 474-481. [CrossRef] [PubMed]
  24. Chan D, Bar-Oz B, Pellerin B, Paciorek C, Klein J, Kapur B, Farine D, Koren G. Population baseline of meconium fatty acid ethyl esters among infants of nondrinking women in Jerusalem and Toronto. Ther Drug Monit. 2003; 25(3): 271-278. [CrossRef] [PubMed]
  25. Laposata M. Fatty acid ethyl esters: ethanol metabolites which mediate ethanol-induced organ damage and serve as markers of ethanol intake. Prog Lipid Res. 1998; 37(5): 307-316. [CrossRef] [PubMed]
  26. Laposata EA, Lange LG. Presence of nonoxidative ethanol metabolism in human organs commonly damaged by ethanol abuse. Science. 1986; 231(4737): 497-499. [CrossRef] [PubMed]
  27. Doyle KM, Bird DA, al-Salihi S, Hallaq Y, Cluette-Brown JE, Goss KA, Laposata M. Fatty acid ethyl esters are present in human serum after ethanol ingestion. J Lipid Res. 1994; 35(3): 428-437. [PubMed]
  28. Doyle KM, Cluette-Brown JE, Dube DM, Bernhardt TG, Morse CR, Laposata M. Fatty acid ethyl esters in the blood as markers for ethanol intake. JAMA. 1996; 276(14): 1152-1156. [CrossRef] [PubMed]
  29. Pragst F, Auwaerter V, Sporkert F, Spiegel K. Analysis of fatty acid ethyl esters in hair as possible markers of chronically elevated alcohol consumption by headspace solid-phase microextraction (HS-SPME) and gas chromatography-mass spectrometry (GC-MS). Forensic Sci Int. 2001; 121(1-2): 76-88. [CrossRef] [PubMed]
  30. Wurst FM, Alexson S, Wolfersdorf M, Bechtel G, Forster S, Alling C, Aradottir S, Jachau K, Huber P, Allen JP, Auwarter V, Pragst F. Concentration of fatty acid ethyl esters in hair of alcoholics: comparison to other biological state markers and self reported-ethanol intake. Alcohol Alcohol. 2004; 39(1): 33-38. [CrossRef] [PubMed]
  31. Auwarter V, Sporkert F, Hartwig S, Pragst F, Vater H, Diefenbacher A. Fatty acid ethyl esters in hair as markers of alcohol consumption. Segmental hair analysis of alcoholics, social drinkers, and teetotalers. Clin Chem. 2001; 47(12): 2114-2123. [PubMed]
  32. Caprara DL, Cartmell LW, Klein J, Koren G. The stability of fatty acid ethyl esters in human hair: measurement of alcohol exposure in the hair of South American and Egyptian mummies. Alcohol Clin Exp Res. 2004; 2840A.
  33. Pragst F, Yegles M. Determination of fatty acid ethyl esters (FAEE) and ethyl glucuronide (EtG) in hair: a promising way for retrospective detection of alcohol abuse during pregnancy? Ther Drug Monit. 2008; 30(2): 255-263.
  34. Pragst F, Balikova MA. State of the art in hair analysis for detection of drug and alcohol abuse. Clin Chim Acta. 2006; 370(1-2): 17-49. [CrossRef] [PubMed]
  35. Kulaga V, Caprara D, Iqbal U, Kapur B, Klein J, Reynolds J, Brien J, Koren G. Fatty acid ethyl esters (FAEE); comparative accumulation in human and guinea pig hair as a biomarker for prenatal alcohol exposure. Alcohol Alcohol. 2006; 41(5): 534-539.
  36. Kintz P. Analytical and practical aspects of drug testing in hair. Boca Raton, FL : CRC Press, 2007.
  37. Borges CR, Wilkins DG, Rollins DE. Amphetamine and N-acetylamphetamine incorporation into hair: an investigation of the potential role of drug basicity in hair color bias. J Anal Toxicol. 2001; 25(4): 221-227. [CrossRef] [PubMed]
  38. Borges CR, Roberts JC, Wilkins DG, Rollins DE. Cocaine, benzoylecgonine, amphetamine, and N-acetylamphetamine binding to melanin subtypes. J Anal Toxicol. 2003; 27(3): 125-134. [CrossRef] [PubMed]
  39. Borges CR, Martin SD, Meyer LJ, Wilkins DG, Rollins DE. Influx and efflux of amphetamine and N-acetylamphetamine in keratinocytes, pigmented melanocytes, and nonpigmented melanocytes. J Pharm Sci. 2002; 91(6): 1523-1535. [CrossRef] [PubMed]
  40. Nakahara Y, Kikura R, Takahashi K. Hair analysis for drugs of abuse XX. Incorporation and behaviors of seven methamphetamine homologs in the rat hair root. Life Sci. 1998; 63(10): 883-893. [CrossRef] [PubMed]
  41. Nakahara Y, Kikura R. Hair analysis for drugs of abuse. XIII. Effect of structural factors on incorporation of drugs into hair: the incorporation rates of amphetamine analogs. Arch Toxicol. 1996; 70(12): 841-849. [CrossRef] [PubMed]
  42. Kulaga V, Valazquez-Armenta Y, Aleksa K, Vergee Z, Koren G. The effect of hair pigment on the incorporation of fatty acid ethyl esters (FAEE). Alcohol Alcohol. 2009; doi:10.1093/alcalc/agn114.
  43. Gearing RE, McNeil T, Lozier FA. Father involvement and fetal alcohol spectrum disorders: developing best practices. JFAS Int. 2005; 3e14.
  44. Abel EL , Tan SE. Effects of paternal alcohol consumption on pregnancy outcome in rats. Neurotoxicol Teratol. 1988; 10(3): 187-192. [CrossRef] [PubMed]
  45. Abel EL. A surprising effect of paternal alcohol treatment on rat fetuses. Alcohol. 1995; 12(1): 1-6. [CrossRef] [PubMed]
  46. Abel EL, Hazlett LS, Berk RS, Mutchnick MG. Neuroimmunotoxic effects in offspring of paternal alcohol consumption. Prog Clin Biol Res. 1990; 32547-32555.
  47. Abel EL. Paternal alcohol exposure and hyperactivity in rat offspring: effects of amphetamine. Neurotoxicol Teratol. 1993; 15(6): 445-449. [CrossRef] [PubMed]
  48. Bielawski DM, Abel EL. Acute treatment of paternal alcohol exposure produces malformations in offspring. Alcohol. 1997; 14(4): 397-401. [CrossRef] [PubMed]
  49. Abel EL. Paternal alcohol consumption affects grooming response in rat offspring. Alcohol. 1991; 8(1): 21-23. [CrossRef] [PubMed]
  50. Gearing RE, Selkirk EK, Koren G, Leslie M, Motz M, Zelazo LB, McNeill T, Lozier FA. Perspectives of mothers with substance use problems on father involvement. Can J Clin Pharmacol. 2008; 15(1): 99-107.
  51. Jaudes PK, Ekwo E, Van Voorhis J. Association of drug abuse and child abuse. Child Abuse Negl. 1995; 19(9): 1065-1075. [CrossRef] [PubMed]
  52. Seljamo S, Aromaa M, Koivusilta L, Rautava P, Sourander A, Helenius H, Sillanpaa M. Alcohol use in families: A 15-year prospective follow-up study. Addiction. 2006; 101(7): 984-992. [CrossRef] [PubMed]
  53. Smith DK, Johnson AB, Pears KC, Fisher PA, DeGarmo DS. Child maltreatment and foster care: Unpacking the effects of prenatal and postnatal parental substance use. Child Maltreat. 2007; 12(2): 150-160. [CrossRef] [PubMed]
  54. Fluke JD, Shusterman GR, Hollinshead DM, Yuan YYT. Longitudinal analysis of repeated child abuse reporting and victimization: Multistate analysis of associated factors. Child Maltreat. 2008; 13(1): 76-88. [CrossRef] [PubMed]
  55. Barr HM, Bookstein FL, O'Malley KD, Connor PD, Huggins JE, Streissguth AP. Binge drinking during pregnancy as a predictor of psychiatric disorders on the structured clinical interview for DSM-IV in young adult offspring. Am J Psychiatry. 2006; 163(6): 1061-1065. [CrossRef] [PubMed]
  56. Baer JS, Sampson PD, Barr HM, Connor PD, Streissguth AP. A 21-year longitudinal analysis of the effects of prenatal alcohol exposure on young adult drinking. Arch Gen Psychiatry. 2003; 60(4): 377-385. [CrossRef] [PubMed]
  57. Baer JS, Barr HM, Bookstein FL, Sampson PD, Streissguth AP. Prenatal alcohol exposure and family history of alcoholism in the etiology of adolescent alcohol problems. J Stud Alcohol. 1998; 59(5): 533-543. [PubMed]
  58. Curtis PA, McCullough C. The impact of alcohol and other drugs on the child welfare system. Child Welfare. 1993; 72(6): 533-542. [PubMed]
  59. Freisthler B, Gruenewald PJ, Remer LG, Lery B, Needell B. Exploring the spatial dynamics of alcohol outlets and child protective services referrals, substantiations, and foster care entries. Child Maltreat. 2007; 12(2): 114-124. [CrossRef] [PubMed]
  60. Freisthler B and Weiss RE. Using Bayesian space-time models to understand the substance use environment and risk for being referred to child protective services. Subst Use Misuse. 2008; 43(2): 239-251. [CrossRef] [PubMed]
  61. Gough P and Fuchs D. Children with FASD-related disabilities receiving services from child welfare agencies in manitoba. Centre of Excellence for Child Welfare. 2006. Accessed January 30, 2008 from
  62. Kulaga V, Pragst F, Fulga N, Koren G. Hair analysis of fatty acid ethyl esters in the detection of excessive drinking in the context of the context of fetal alcohol spectrum disorders. Ther Drug Monit, in Press.
  63. Adlaf EM, Begin P, Sawka E. Canadian Addiction Survey (CAS): A national survey of Canadians' use of alcohol and other drugs: Prevalence of use and related harms: Detailed Report. Ottawa : Canadian Centre of Substance Abuse, 2005.
  64. Pragst F, Yegles M. In: Kintz P (Ed.). Alcohol markers in hair. Analytical and practical aspects of drug testing in hair Boca Raton: CRC Press, 2007.
  65. Skopp G, Schmitt G, Potsch L, Dronner P, Aderjan R, Mattern R. Ethyl glucuronide in human hair. Alcohol Alcohol. 2000; 35(3): 283-285. [CrossRef] [PubMed]
  66. Alt A, Janda I, Seidl S, Wurst FM. Determination of ethyl glucuronide in hair samples. Alcohol Alcohol. 2000; 35(3): 313-314. [CrossRef] [PubMed]
  67. Janda I, Weinmann W, Kuehnle T, Lahode M, Alt A. Determination of ethyl glucuronide in human hair by SPE and LC-MS/MS. Forensic Sci Int. 2002; 128(1-2): 59-65. [CrossRef] [PubMed]
  68. Yegles M, Labarthe A, Auwarter V, Hartwig S, Vater H, Wennig R, Pragst F. Comparison of ethyl glucuronide and fatty acid ethyl ester concentrations in hair of alcoholics, social drinkers and teetotallers. Forensic Sci Int. 2004; 145(2-3): 167-173. [CrossRef] [PubMed]
  69. Jurado C, Soriano T, Gimenez MP, Menendez M. Diagnosis of chronic alcohol consumption. Hair analysis for ethyl-glucuronide. Forensic Sci Int. 2004; 145(2-3): 161-166. [CrossRef] [PubMed]
  70. Klys M, Scislowski M, Rojek S, Kolodziej J. A fatal clomipramine intoxication case of a chronic alcoholic patient: application of postmortem hair analysis method of clomipramine and ethyl glucuronide using LC/APCI/MS. Leg Med (Tokyo). 2005; 7(5): 319-325. [CrossRef] [PubMed]
  71. Politi L, Morini L, Leone F, Polettini A. Ethyl glucuronide in hair: Is it a reliable marker of chronic high levels of alcohol consumption? Addiction. 2006; 101(10): 1408-1412.
  72. Morini L, Politi L, Groppi A, Stramesi C, Polettini A. Determination of ethyl glucuronide in hair samples by liquid chromatography/electrospray tandem mass spectrometry. J Mass Spectrom. 2006; 41(1): 34-42. [CrossRef] [PubMed]
  73. Politi L, Zucchella A, Morini L, Stramesi C, Polettini A. Markers of chronic alcohol use in hair: comparison of ethyl glucuronide and cocaethylene in cocaine users. Forensic Sci Int. 2007; 172(1): 23-27. [CrossRef] [PubMed]
  74. Politi L, Morini L, Mari F, Groppi A, Bertol E. Ethyl glucuronide and ethyl sulfate in autopsy samples 27 years after death. Int J Legal Med. 2008; 122507-122509.
  75. Appenzeller BM, Schuman M, Yegles M, Wennig R. Ethyl glucuronide concentration in hair is not influenced by pigmentation. Alcohol Alcohol. 2007; 42(4): 326-327. [CrossRef] [PubMed]
  76. Appenzeller BM, Agirman R, Neuberg P, Yegles M, Wennig R. Segmental determination of ethyl glucuronide in hair: a pilot study. Forensic Sci Int. 2007; 173(2-3): 87-92. [CrossRef] [PubMed]